化学性质:
规格 | 10mM (in 1mL DMSO) 50mg 100mg |
CAS | 489-32-7 |
别名 | N/A |
化学名 | 5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one |
分子式 | C33H40O15 |
分子量 | 676.65 |
溶解度 | ≥ 30.5mg/mL in DMSO |
储存条件 | Store at 2-8°C |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice |
产品描述:
Icariin exhibits inhibitory effects on cGMP-specific phosphodiesterase PDE5 and cAMP-specific phosphodiesterase PDE4 activities. Phosphodiesterase (PDE) is a crucial regulator of cAMP/PKA signaling. PDEs are encoded by 21 genes which can be sdivided into 11 families according to the substrate specificities and subcellular localization. PDEs are widely expressed in neurons. PDE5 has been implicated in regulating some physiological processes such as smooth muscle relaxation and neuronal survival. PDE4 has been associated with the DARPP-32 signaling pathway and dopaminergic neurotransmission [1].
In vitro: Icariin inhibited the activity of PDE5 and PDE4 in a dose- andconcentration-dependent manner. The IC50of icariin on PDE5 was 0.43 μM and the IC50 on PDE4 was 73.50 μM. Icariin showed a selective inhibitory effect on cGMP-specific PDE5 compared to cAMP-specific PDE4 [2].Icariincould also enhance the osteogenic differentiation of rat primary bone marrow stromal cells [3].
In vivo: In castrated rats, a 4-week oral administration of icariinat 1 mg/kg/day and 5 mg/kg/day improved the erectile function and increased nNOS and iNOS expression [4].Icariin also showed its effect on stimulating angiogenesis in human endothelial cells [5].
特别提醒:
1. 本产品仅供科研使用。请勿用于医药、临床诊断或治疗,食品及化妆品等用途。请勿存放于普通住宅区。
2. 为了您的安全和健康,请穿好实验服并佩戴一次性手套和口罩操作。
标签:Icariin
联系人:高小姐
手 机:13585831301
Q Q:3004967995
座 机:021-59541103
传 真:021-60443211
地 址:上海嘉定区嘉罗公路1661